Skip to content

Efficacy of local diclofenac application in third molar surgery: a randomized clinical trial

Efficacy of local diclofenac application in third molar surgery: a randomized clinical trial

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
TCTR
Registry ID
TCTR20210915002
Enrollment
40
Registered
2021-09-15
Start date
2021-10-06
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patients with a bilateral impacted mandibular molar that require both osteotomy and odontosection. Mandibular third molar, diclofenac, NSAID, dental pain

Interventions

0.1% Diclofenac and collagen sponge in surgical wound.,Collagen sponge PBS in surgical wound.
Experimental Drug,Placebo Comparator No treatment
Diclofenac,Placebo

Sponsors

Faculty of Dentistry, Chiang Mai University , Chiang Mai, Thailand
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 35 Years

Inclusion criteria

Inclusion criteria: 1. The patients aged between 18 to 35 years old. 2. All participants must have a healthy status (ASA I-II according to the classification of the American Society of Anesthesiologists). 3. All participants are patients at an Oral and Maxillofacial surgery clinic, the Faculty of Dentistry, Chiang Mai University who require surgical removal of bilateral impacted mandibular molar that require both osteotomy and odontosection.

Exclusion criteria

Exclusion criteria: 1. Pregnancy or breastfeeding women. 2. History of allergic to diclofenac or other NSAIDs. 3. Patients have any conditions that contraindicated the use of NSAIDs. 4. Patients who used NSAIDs 14 days prior to surgical procedures. 5. History of having ulcers or bleeding in the digestive tract, coagulation disorders or hepatic/renal impairment. 6. Patients who have an infection and/or pericoronitis prior to surgical procedures. 7. Patient who refuses to take any medicine. 8. Patient who is unable to report the collecting data.

Design outcomes

Primary

MeasureTime frame
pain intensity when first time pain emerged, then at 6 and 24 hours postoperatively VAS score

Secondary

MeasureTime frame
swelling measurements preoperatively and at the day 2 and day 7 postoperatively facial distances between lower border of tragus to soft tissue pogonion in a millimeters,Trismus measurements preoperatively and at the day 2 and day 7 postoperatively distances between the incisal edges of upper and lower incisors in millimeters,Local adverse effects 1 week after the surgery Incidence rate

Countries

Thailand

Contacts

Public ContactChayarop Supanchart

Chiang Mai University

supanchart.c@yahoo.com6653944455

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026